ARTICLE | Company News
ImClone deal
July 11, 1994 7:00 AM UTC
EGFr is over-expressed on the surface of many cancer cells, including squamous, breast, ovarian, colorectal and lung cancers. IMCL hopes that antibodies directed against EGFr will inhibit cancer cell growth by limiting the cells' access to necessary growth factors. ...